Copyright
©The Author(s) 2024.
World J Gastrointest Pharmacol Ther. May 28, 2024; 15(3): 92305
Published online May 28, 2024. doi: 10.4292/wjgpt.v15.i3.92305
Published online May 28, 2024. doi: 10.4292/wjgpt.v15.i3.92305
Variables | Total, n (%) | Hospital stay in days | Mortality in 7 d | Mortality in 30 d | Re-bleed in 24 h | Re-current bleed in 7 d | |||||
≤ 5 (n = 104) | > 5 (n = 38) | No (n = 127) | Yes (n = 15) | No (n = 121) | Yes (n = 21) | No (n = 122) | Yes (n = 20) | No (n = 116) | Yes (n = 26) | ||
Smoking | |||||||||||
Yes | 31 (21.8) | 24 (77.4) | 7 (22.6) | 29 (93.5) | 2 (6.5) | 29 (93.5) | 2 (6.5) | 27 (87.1) | 4 (12.9) | 26 (83.9) | 5 (16.1) |
No | 111 (78.2) | 80 (72.1) | 31 (27.9) | 98 (88.3) | 13 (11.7) | 92 (82.9) | 19 (17.1) | 95 (85.6) | 16 (14.4) | 90 (81.1) | 21 (18.9) |
Steroids | |||||||||||
Yes | 8 (5.6) | 7 (87.5) | 1 (12.5) | 7 (87.5) | 1 (12.5) | 7 (87.5) | 1 (12.5) | 7 (87.5) | 1 (12.5) | 7 (87.5) | 1 (12.5) |
No | 134 (94.4) | 97 (72.4) | 37 (27.6) | 120 (89.6) | 14 (10.4) | 114 (85.1) | 20 (14.9) | 115 (85.8) | 19 (14.2) | 109 (81.3) | 25 (18.7) |
H. pylori | |||||||||||
Yes | 26 (18.3) | 20 (76.9) | 6 (23.1) | 24 (92.3) | 2 (7.7) | 23 (88.5) | 3 (11.5) | 22 (84.6) | 4 (15.4) | 20 (76.9) | 6 (23.1) |
No | 116 (81.7) | 84 (72.4) | 32 (27.6) | 103 (88.8) | 13 (11.2) | 98 (84.5) | 18 (15.5) | 100 (86.2) | 16 (13.8) | 96 (82.8) | 20 (17.2) |
Antiplatele | |||||||||||
Yes | 47 (33.1) | 34 (72.3) | 13 (27.7) | 37 (78.7) | 10 (21.3)b | 36 (76.6) | 11 (23.4)a | 37 (78.7) | 10 (21.3) | 35 (74.5) | 12 (25.5) |
No | 95 (66.9) | 70 (73.7) | 25 (26.3) | 90 (94.7) | 5 (5.3) | 85 (89.5) | 10 (10.5) | 85 (89.5) | 10 (10.5) | 81 (85.3) | 14 (14.7) |
Alternative medications | |||||||||||
Yes | 56 (39.4) | 39 (69.6) | 17 (30.4) | 47 (83.9) | 9 (16.1) | 44 (78.6) | 12 (21.4) | 44 (78.6) | 12 (21.4)a | 43 (76.8) | 13 (23.2) |
No | 86 (60.6) | 65 (75.6) | 21 (24.4) | 80 (93.0) | 6 (7.0) | 77 (89.5) | 9 (10.5) | 78 (90.7) | 8 (9.3) | 73 (84.9) | 13 (15.1) |
Forrest classification | |||||||||||
I | 18 (12.7) | 10 (55.6) | 8 (44.4) | 18 (100.0) | 0 | 17 (94.4) | 1 (5.6) | 13 (72.2) | 5 (27.8) | 11 (61.1) | 7 (38.9)a |
II | 21 (14.8) | 14 (66.7) | 7 (33.3) | 18 (85.7) | 3 (14.3) | 17 (81.0) | 4 (19.0) | 17 (81.0) | 4 (19.0) | 16 (76.2) | 5 (23.8) |
III | 103 (72.5) | 80 (77.7) | 23 (22.3) | 91 (88.3) | 12 (11.7) | 87 (84.5) | 16 (15.5) | 92 (89.3) | 11 (10.7) | 89 (86.4) | 14 (13.6) |
- Citation: Butt N, Usmani MT, Mehak N, Mughal S, Qazi-Arisar FA, Mohiuddin G, Khan G. Risk factors and outcomes of peptic ulcer bleed in a Pakistani population: A single-center observational study. World J Gastrointest Pharmacol Ther 2024; 15(3): 92305
- URL: https://www.wjgnet.com/2150-5349/full/v15/i3/92305.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v15.i3.92305